5
Citurgia Biochemicals
CITURGIABIOCHEMICALSLTD NSE
Citurgia Biochemicals
CommoditiesNSE: CITURGIABIOCHEMICALSLTD BSE: 506373 Chemicals & Petrochemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹1,421 Cr
P/E Ratio
-1,793.3
EBITDA
₹-0.52 Cr
Return on Equity
6.05%
Debt to Equity
0
Book Value
₹-0.77
52W High
₹212
52W Low
₹47.4
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Revenue Growth
—
Net Income Growth
85% higher than
3Y
Cash Flow Change
14.29% higher than
3Y
ROE
-16.44% lower than
3Y
ROCE
8.43% lower than
3Y
EBITDA Margin (Avg.)
—
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.04 | 0.09 | 0.05 | 0.07 | 0.04 | 0.08 | 0.05 | 0.06 | 0.03 | 0.05 | 0.23 | 0.2 | 0.03 |
| Operating Profit | -0.04 | -0.09 | -0.05 | -0.07 | -0.04 | -0.08 | -0.05 | -0.06 | -0.03 | -0.05 | -0.23 | -0.2 | -0.03 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 |
| PBT | -0.09 | -0.15 | -0.11 | -0.13 | -0.09 | -0.14 | -0.11 | -0.12 | -0.08 | -0.11 | -0.29 | -0.26 | -0.08 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.09 | -0.15 | -0.11 | -0.13 | -0.09 | -0.14 | -0.1 | -0.12 | -0.08 | -0.11 | -0.29 | -0.26 | -0.08 |
| EPS in Rs | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.18 | 0.16 | 0.1 | 0.18 | 0.24 | 0.12 | 0.37 | 0.18 | 0.21 | 0.25 | 0.2 | 0.52 | 0.51 |
| Operating Profit | -0.18 | -0.16 | -0.1 | -0.18 | -0.24 | -0.12 | -0.37 | -0.18 | -0.21 | -0.25 | -0.2 | -0.52 | -0.51 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.58 | 0.5 | 0.43 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| PBT | -0.76 | -0.66 | -0.53 | -0.55 | -0.56 | -0.4 | -0.61 | -0.41 | -0.44 | -0.48 | -0.43 | -0.75 | -0.74 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -0.76 | -0.66 | -0.54 | -0.55 | -0.56 | -0.4 | -0.61 | -0.4 | -0.44 | -0.48 | -0.42 | -0.74 | -0.74 |
| EPS in Rs | -0.06 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | -0.03 | -0.06 | -0.06 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 |
| Reserves | -28.35 | -29.01 | -29.55 | -30.1 | -30.66 | -31.06 | -31.67 | -32.08 | -32.51 | -32.99 | -33.41 | -34.15 |
| Borrowings | 4.49 | 4.5 | 5.15 | 6.45 | 6.48 | 6.48 | 6.49 | 6.49 | 6.55 | 6.77 | 6.83 | 6.89 |
| Other Liabilities | 8.59 | 9.67 | 9.93 | 10.05 | 10.13 | 10.13 | 10.36 | 10.6 | 10.73 | 10.84 | 10.92 | 11.31 |
| Total Liabilities | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.6 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
| Fixed Assets | 3.66 | 3.16 | 2.73 | 2.36 | 2.04 | 1.76 | 1.52 | 1.3 | 1.07 | 0.85 | 0.62 | 0.4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7.49 | 8.42 | 9.22 | 10.46 | 10.33 | 10.21 | 10.08 | 10.13 | 10.12 | 10.19 | 10.14 | 10.07 |
| Total Assets | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.6 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | -0.13 |
| Investing | 0 | 0 | 0.13 | -0.07 | 0.02 | 0.06 | 0.15 | 0.01 | 0.04 | -0.05 | 0.07 | 0.08 |
| Financing | 0 | 0 | 0.65 | 1.3 | 0.03 | 0 | 0.01 | 0 | 0.06 | 0.22 | 0.06 | 0.06 |
| Net Cash Flow | -0.03 | -0.08 | 0.27 | -0.09 | -0.15 | -0.06 | 0.01 | -0.01 | 0.02 | 0.03 | 0.01 | 0.01 |
| Free Cash Flow | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | -0.13 |
| CFO/OP | 17 | 50 | 510 | 733 | 79 | 92 | 41 | 17 | 33 | 56 | 60 | 25 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -25.94% | -29.53% | -26.97% | -22.96% | -22.36% | -19.61% | -39.61% | -39.61% | -68.22% | -145.45% | -2150% | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Citurgia Biochemicals insights
49 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
21 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026 21 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14h - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026 14h - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026
4
Closure of Trading Window
31 Mar - Trading window closed 01-Apr-2026 until two days after Board meeting for audited results for quarter/year ended 31-Mar-2026. 31 Mar - Trading window closed 01-Apr-2026 until two days after Board meeting for audited results for quarter/year ended 31-Mar-2026.
5
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Capacity Addition
17h - Lease for 1,41,392 sq ft in Chennai; ~2,605 desks; ₹35 Crore investment by July 2026. 17h - Lease for 1,41,392 sq ft in Chennai; ~2,605 desks; ₹35 Crore investment by July 2026.
1
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 8 Sept 2026
General_Announcements
4
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 24 Jul 2026
General_Announcements
Frequently Asked Questions about Citurgia Biochemicals
What does Citurgia Biochemicals Ltd do?
Incorporated in 1969, Citurgia Biochemicals
Ltd deals in the manufacturing and trading
of citric acid.[1]
Where is Citurgia Biochemicals Ltd (506373) listed?
Citurgia Biochemicals Ltd trades as CITURGIABIOCHEMICALSLTD on the NSE and under code 506373 on the BSE.
Which sector does Citurgia Biochemicals Ltd belong to?
Citurgia Biochemicals Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.
What is the market capitalisation of Citurgia Biochemicals Ltd?
Citurgia Biochemicals Ltd has a market capitalisation of ₹1,421 Cr, which places it in the Small Cap band.
What is the PE ratio of Citurgia Biochemicals Ltd?
Citurgia Biochemicals Ltd trades at a PE ratio of -1793.30, against a book value of ₹-0.77 per share.
What is the 52-week high and low of Citurgia Biochemicals Ltd?
Over the last 52 weeks Citurgia Biochemicals Ltd has traded between ₹47.4 and ₹212.
What is the Return on Equity (ROE) of Citurgia Biochemicals Ltd?
Citurgia Biochemicals Ltd reported a return on equity of 6.05%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 1969, Citurgia Biochemicals Ltd deals in the manufacturing and trading of citric acid.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506373.md for Citurgia Biochemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.